ArticleBMC psychiatry2023
ARFID Genes and Environment (ARFID-GEN): study protocol.
Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05605067 (Genetic Architecture of Avoidant/Restrictive Food Intake Disorder), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Genetic Architecture of Avoidant/Restrictive Food Intake Disorder
Who cites it
12 citing papers in PubMed, 13 citations in OpenAlex.
- Associations Between Avoidant/Restrictive Food Intake Disorder Dimensions and Obsessive-Compulsive Symptomatology.European eating disorders review : the journal of the Eating Disorders Association · 2026Article
- Co-Occurring Weight- and/or Shape-Motivated Restriction in 5747 Adults With Probable Avoidant/Restrictive Food Intake Disorder.The International journal of eating disorders · 2026Article
- Prevalence of avoidant/restrictive food intake disorder in children and adolescents with rare diseases.Orphanet journal of rare diseases · 2026Observational
- Engaging migrants and immigrants in genetics research.Nature genetics · 2025Review
- The Psychiatric Genomics Consortium: discoveries and directions.The lancet. Psychiatry · 2025Review
- Suicidal ideation and avoidant/restrictive food intake disorder: Findings from the ARFID-GEN study.Psychiatry research · 2025Article
- The Eating Disorders Genetics Initiative 2 (EDGI2): study protocol.BMC psychiatry · 2025Article
- Validating Online Parent- and Self-Report Screening Methods for Avoidant/Restrictive Food Intake Disorder.The International journal of eating disorders · 2025Article
- Article
- Measurement Invariance on the Nine-Item Avoidant/Restrictive Food Intake Disorder Screen (NIAS) by Age and Reporter Status: Comparing ARFID Symptoms Among Self-Reporting Adults and Adolescents and Parent Reports of Children and Adolescents.The International journal of eating disorders · 2025Article
- Eating behaviour and eating disorders in individuals with rare neurodevelopmental variants: current knowledge and future research directions.Frontiers in psychiatry · 2025Article
- Neuroimaging insights into brain mechanisms of early-onset restrictive eating disorders.Nature. Mental health · 2025Article
Corrections and comments
- Update of
Authors and funding
18 authors at 6 institutions in 5 countries.
Funding
Abstract
backgroundThe Avoidant Restrictive Food Intake Disorder - Genes and Environment (ARFID-GEN) study is a study of genetic and environmental factors that contribute to risk for developing ARFID in children and adults.
methodsA total of 3,000 children and adults with ARFID from the United States will be included. Parents/guardians and their children with ARFID (ages 7 to 17) and adults with ARFID (ages 18 +) will complete comprehensive online consent, parent verification of child assent (when applicable), and phenotyping. Enrolled participants with ARFID will submit a saliva sample for genotyping. A genome-wide association study of ARFID will be conducted. DISCUSSION: ARFID-GEN, a large-scale genetic study of ARFID, is designed to rapidly advance the study of the genetics of eating disorders. We will explicate the genetic architecture of ARFID relative to other eating disorders and to other psychiatric, neurodevelopmental, and metabolic disorders and traits. Our goal is for ARFID to deliver "actionable" findings that can be transformed into clinically meaningful insights.
trial registrationARFID-GEN is a registered clinical trial: clinicaltrials.gov NCT05605067.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.